TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life

TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life

Luca Richeldi,1 Pietro Schino,2 Elena Bargagli,3 Alberto Ricci,4 Alberto Rocca,5 Francesca Marchesani,6 Alfio Pennisi,7 Gianna Camiciottoli,8,9 Maria D’Amato,10 Francesco Macagno,1 Ulrica Scaffidi Argentina,11 Eleonora Ingrassia,11 Alessio Piraino11 1Division of Pulmonary Medicine, Fondazione Policl...

Full description

Bibliographic Details
Main Authors: Richeldi L, Schino P, Bargagli E, Ricci A, Rocca A, Marchesani F, Pennisi A, Camiciottoli G, D'Amato M, Macagno F, Scaffidi Argentina U, Ingrassia E, Piraino A
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:International Journal of COPD
Subjects:
beclometasone/formoterol/glycopyrronium
chronic obstructive pulmonary disease
real-world
fixed triple therapy
adherence
patient-reported outcomes
Online Access:https://www.dovepress.com/tritrial-the-impact-of-fixed-triple-therapy-with-beclometasoneformoter-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/tritrial-the-impact-of-fixed-triple-therapy-with-beclometasoneformoter-peer-reviewed-fulltext-article-COPD

Similar Items